日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Expanding the LuxR-type receptor functional repertoire: Protein-protein interactions in quorum sensing regulation

扩展 LuxR 型受体的功能谱：群体感应调控中的蛋白质-蛋白质相互作用

期刊:PLoS Pathogens
影响因子:4.9
doi:10.1371/journal.ppat.1014091
Mallery, Caleb P; Paczkowski, Jon E
信号转导
发表日期：2026
文献求助 收藏

Ligand binding drives proteolysis of the SmcR master transcription factor and controls quorum sensing-state transitions in Vibrio species

配体结合驱动SmcR主转录因子的蛋白水解，并控制弧菌属的群体感应状态转换。

期刊:mBio
影响因子:4.7
doi:10.1128/mbio.03445-25
Rasal, Tanmaya A; Mallery, Caleb P; Liang, Biqing; Brockley, Matthew W; Simpson, Chelsea A; Padgett, Abigail D; Geyman, Logan J; Andrew, Finley J; Brown, Laura C; Paczkowski, Jon E; van Kessel, Julia C
发表日期：2026
文献求助 收藏

Response to: Letter to the Editor Regarding "Comparative Effectiveness of FF/1 UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy"

回复：致编辑的信，内容关于“FF/1 UMEC/VI 和 BUD/GLY/FORM 在 COPD 患者从双联疗法升级治疗中的疗效比较”

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03477-0
Wedzicha, Jadwiga A; Noorduyn, Stephen G; Di Boscio, Valentina; Le Rouzic, Olivier; Majumdar, Anurita; Paczkowski, Rosirene; Weng, Stephen; Germain, Guillaume; Laliberté, François; Mannino, David
COPD
慢性阻塞性肺疾病
发表日期：2026
文献求助 收藏

FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up from Dual Therapy Stratified by Exacerbations and Prior Dual Therapy: A Subgroup Analysis of a Comparative Effectiveness Study

在慢性阻塞性肺疾病（COPD）患者中，根据急性加重情况和既往双联疗法分层，评估从双联疗法升级至FF/UMEC/VI和BUD/GLY/FORM方案的疗效：一项比较疗效研究的亚组分析

期刊:Advances in Therapy
影响因子:
doi:10.1007/s12325-025-03470-7
Wedzicha, Jadwiga A; Noorduyn, Stephen G; Di Boscio, Valentina; Le Rouzic, Olivier; Majumdar, Anurita; Paczkowski, Rosirene; Weng, Stephen; Germain, Guillaume; Laliberté, François; Mannino, David
COPD
慢性阻塞性肺疾病
发表日期：2026
文献求助 收藏

Evolution of PqsE as a Pseudomonas aeruginosa-specific regulator of LuxR-type receptors: insights from Pseudomonas and Burkholderia

PqsE作为铜绿假单胞菌特异性LuxR型受体调节因子的进化：来自铜绿假单胞菌和伯克霍尔德菌的启示

期刊:mBio
影响因子:4.7
doi:10.1128/mbio.00646-25
Mallery, Caleb P; Simanek, Kayla A; Pope, Autumn N; Paczkowski, Jon E
信号转导
发表日期：2025
文献求助 收藏

Pseudomonas aeruginosa alkyl quinolone response is dampened by Enterococcus faecalis

粪肠球菌会抑制铜绿假单胞菌对烷基喹诺酮类药物的反应。

期刊:mBio
影响因子:4.7
doi:10.1128/mbio.03320-24
Fink, Maggie M; Weaver, Abigail A; Parmar, Dharmeshkumar; Paczkowski, Jon E; Li, Lingyun; Klaers, Maggie K; Junker, Ella A; Jarocki, Elizabeth A; Sweedler, Jonathan V; Shrout, Joshua D
发表日期：2025
文献求助 收藏

Adherence and Persistence with Single-Inhaler Triple Therapy Among Patients with COPD Using Commercial and Medicare Advantage US Health Plan Claims Data

利用美国商业和联邦医疗保险优势计划的理赔数据，评估慢性阻塞性肺病患者使用单吸入器三联疗法的依从性和持续性

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-03055-w
Young, Corinne; Lee, Lydia Y; DiRocco, Kristi K; Germain, Guillaume; Klimek, Jacob; Laliberté, François; Lejeune, Dominique; Noorduyn, Stephen G; Paczkowski, Rosirene
发表日期：2025
文献求助 收藏

Medicare Advantage Population in the United States: Outcomes of Patients with Asthma Treated with ICS/LABA Before and After Initiation with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)

美国医疗保险优势计划人群：接受 ICS/LABA 治疗的哮喘患者在开始使用糠酸氟替卡松/乌美溴铵/维兰特罗 (FF/UMEC/VI) 前后的治疗结果

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-03083-6
Baptist, Alan P; Germain, Guillaume; Klimek, Jacob; Laliberté, François; Schell, Robert C; Forero-Schwanhaeuser, Sergio; Moore, Alison; Noorduyn, Stephen G; Paczkowski, Rosirene
哮喘
发表日期：2025
文献求助 收藏

Comparative Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol and Budesonide/Glycopyrrolate/Formoterol Fumarate among US Patients with Chronic Obstructive Pulmonary Disease

在美国慢性阻塞性肺疾病患者中，氟替卡松糠酸酯/乌美溴铵/维兰特罗与布地奈德/格隆溴铵/富马酸福莫特罗的疗效比较

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-024-03088-1
Mannino, David; Weng, Stephen; Germain, Guillaume; Boudreau, Julien; Tardif-Samson, Anabelle; Forero-Schwanhaeuser, Sergio; Laliberté, François; Gravelle, Patrick; Compton, Chris H; Noorduyn, Stephen G; Paczkowski, Rosirene
慢性阻塞性肺疾病
发表日期：2025
文献求助 收藏

Comparative Effectiveness of FF/UMEC/VI and BUD/GLY/FORM in Patients with COPD Stepping Up From Dual Therapy

FF/UMEC/VI 和 BUD/GLY/FORM 在 COPD 患者从双联疗法升级治疗中的疗效比较

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03295-4
Wedzicha, Jadwiga A; Noorduyn, Stephen G; Di Boscio, Valentina; Le Rouzic, Olivier; Majumdar, Anurita; Paczkowski, Rosirene; Weng, Stephen; Germain, Guillaume; Laliberté, François; Mannino, David
COPD
慢性阻塞性肺疾病
发表日期：2025
文献求助 收藏